Rankings
▼
Calendar
RNA Q1 2019 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1M
Operating Income
-$2M
Net Income
-$3M
EPS (Diluted)
$-0.12
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$17,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
-$8M
Cash & Equivalents
-$3M
← FY 2019
All Quarters
Q2 2019 →